Literature DB >> 6538515

Human endothelial cells contain one type of plasminogen activator.

P Kristensen, L I Larsson, L S Nielsen, J Grøndahl-Hansen, P A Andreasen, K Danø.   

Abstract

At least two types of animal plasminogen activating enzymes exist, differing in amino acid sequence, molecular mass and immunological reactivity: the urokinase-type and the tissue-type plasminogen activators. By affinity chromatography with monoclonal antibodies, we have purified the human activators of both types to homogeneity. Using immunocytochemistry with rabbit antibodies raised against these preparations, we now demonstrate that the plasminogen activator present in endothelium of veins and other blood vessels is of the tissue-type. No urokinase-type plasminogen activator immunoreactivity was detected in endothelial cells in the intact organism. These findings support the assumption that mobilization of plasmin for different purposes may involve different types of plasminogen activators, and that the plasminogen activator involved in thrombolysis is of the tissue-type.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6538515     DOI: 10.1016/0014-5793(84)80201-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.

Authors:  Franz Wiesbauer; Christoph Kaun; Gerlinde Zorn; Gerald Maurer; Kurt Huber; Johann Wojta
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 2.  Regulatory functions of the coronary endothelium.

Authors:  V W van Hinsbergh
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

3.  Tissue-type plasminogen activator in rat adrenal medulla.

Authors:  P Kristensen; D M Hougaard; L S Nielsen; K Danø
Journal:  Histochemistry       Date:  1986

4.  Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.

Authors:  Joshua M Barnett; Gary W McCollum; Jessica A Fowler; James J-W Duan; Jesse D Kay; Rui-Qin Liu; David P Bingaman; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

5.  Immunohistological detection of Saruplase (recombinant single-chain urokinase-type plasminogen activator) in normal rat tissue.

Authors:  T Wöhrmann; T Matthiesen; H Beier; L Flohé
Journal:  Histochemistry       Date:  1991

6.  Human endothelial cell line, ECV304, produces pro-urokinase.

Authors:  K Takahashi; Y Sawasaki
Journal:  In Vitro Cell Dev Biol       Date:  1991-10

7.  Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma.

Authors:  P Kristensen; C Pyke; L R Lund; P A Andreasen; K Danø
Journal:  Histochemistry       Date:  1990

8.  Localization of the binding site of tissue-type plasminogen activator to fibrin.

Authors:  A Ichinose; K Takio; K Fujikawa
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

9.  Plasminogen activator inhibitor (type-1) in rat adrenal medulla.

Authors:  J Eriksen; P Kristensen; C Pyke; K Danø
Journal:  Histochemistry       Date:  1989

10.  Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.

Authors:  K Yamamoto; D J Loskutoff
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.